IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

PEDRO O DIAZ

Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease

NPI
1578532800
CMS profile
664534
Location
HIALEAH, FL

General Payments · PY2018–2024

$97,222.45

  • Reported across 402 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,115.79

48 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Cardiovascular Disease FL All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,115.79 48

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
NOVARTIS PHARMACEUTICALS CORPORATION $329.57 25
Abbott Laboratories $171.91 1
E.R. Squibb & Sons, L.L.C. $121.11 5
Medtronic, Inc. $72.82 1
Lexicon Pharmaceuticals, Inc. $63.08 2
Actelion Pharmaceuticals US, Inc. $62.29 2
Acerta Pharma LLC $62.26 3
Amgen Inc. $47.50 2
Janssen Pharmaceuticals, Inc $40.36 2
PFIZER INC. $38.65 1
SANOFI-AVENTIS U.S. LLC $33.21 1
IMPULSE DYNAMICS (USA) INC. $27.41 1
Merck Sharp & Dohme Corporation $23.85 1
SCPHARMACEUTICALS INC. $21.77 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $20,059.82 121
PY2019 $2,962.55 63
PY2020 $14,108.14 35
PY2021 $52,329.12 77
PY2022 $5,744.77 42
PY2023 $902.26 16
PY2024 $1,115.79 48

Payment records · PY2024 (48)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $171.91 04/09/2024 Food and Beverage Undisputed 01/23/2026 1125133336 CMS
Actelion Pharmaceuticals US, Inc. $37.82 02/15/2024 Food and Beverage Undisputed 01/23/2026 1078876436 CMS
Actelion Pharmaceuticals US, Inc. $24.47 11/20/2024 Food and Beverage Undisputed 01/23/2026 1078876392 CMS
Amgen Inc. $20.96 09/04/2024 Food and Beverage Undisputed 01/23/2026 1115574499 CMS
Amgen Inc. $26.54 11/13/2024 Food and Beverage Undisputed 01/23/2026 1115574507 CMS
AstraZeneca Pharmaceuticals LP $20.00 06/12/2024 Food and Beverage Undisputed 01/23/2026 1105509810 CMS
AstraZeneca Pharmaceuticals LP $22.86 08/21/2024 Food and Beverage Undisputed 01/23/2026 1104555888 CMS
AstraZeneca Pharmaceuticals LP $19.40 11/06/2024 Food and Beverage Undisputed 01/23/2026 1105450953 CMS
E.R. Squibb & Sons, L.L.C. $24.76 02/07/2024 Food and Beverage Undisputed 01/23/2026 1101441437 CMS
E.R. Squibb & Sons, L.L.C. $19.70 04/22/2024 Food and Beverage Undisputed 01/23/2026 1101441465 CMS
E.R. Squibb & Sons, L.L.C. $23.00 07/30/2024 Food and Beverage Undisputed 01/23/2026 1101441481 CMS
E.R. Squibb & Sons, L.L.C. $29.01 10/23/2024 Food and Beverage Undisputed 01/23/2026 1101441501 CMS
E.R. Squibb & Sons, L.L.C. $24.64 11/26/2024 Food and Beverage Undisputed 01/23/2026 1101441503 CMS
Impulse Dynamics (USA) Inc. $27.41 01/31/2024 Food and Beverage Undisputed 01/23/2026 1100408664 CMS
Janssen Pharmaceuticals, Inc $21.14 06/05/2024 Food and Beverage Undisputed 01/23/2026 1077961498 CMS
Janssen Pharmaceuticals, Inc $19.22 08/07/2024 Food and Beverage Undisputed 01/23/2026 1077960882 CMS
Lexicon Pharmaceuticals, Inc. $34.47 04/17/2024 Food and Beverage Undisputed 01/23/2026 1081708369 CMS
Lexicon Pharmaceuticals, Inc. $28.61 07/17/2024 Food and Beverage Undisputed 01/23/2026 1081708367 CMS
Medtronic, Inc. $72.82 01/25/2024 Food and Beverage Undisputed 01/23/2026 1119383006 CMS
Merck Sharp & Dohme LLC $23.85 08/14/2024 Food and Beverage Undisputed 01/23/2026 1141674053 CMS
Novartis Pharmaceuticals Corporation $8.42 01/25/2024 Food and Beverage Undisputed 01/23/2026 1086846109 CMS
Novartis Pharmaceuticals Corporation $5.68 01/31/2024 Food and Beverage Undisputed 01/23/2026 1086846111 CMS
Novartis Pharmaceuticals Corporation $12.67 02/07/2024 Food and Beverage Undisputed 01/23/2026 1086846113 CMS
Novartis Pharmaceuticals Corporation $6.68 02/15/2024 Food and Beverage Undisputed 01/23/2026 1086846119 CMS
Novartis Pharmaceuticals Corporation $10.26 02/26/2024 Food and Beverage Undisputed 01/23/2026 1086846121 CMS
Novartis Pharmaceuticals Corporation $27.15 02/28/2024 Food and Beverage Undisputed 01/23/2026 1086846123 CMS
Novartis Pharmaceuticals Corporation $27.84 03/13/2024 Food and Beverage Undisputed 01/23/2026 1086846125 CMS
Novartis Pharmaceuticals Corporation $6.91 03/13/2024 Food and Beverage Undisputed 01/23/2026 1086846127 CMS
Novartis Pharmaceuticals Corporation $11.91 03/15/2024 Food and Beverage Undisputed 01/23/2026 1086846115 CMS
Novartis Pharmaceuticals Corporation $12.03 03/28/2024 Food and Beverage Undisputed 01/23/2026 1086846117 CMS
Novartis Pharmaceuticals Corporation $7.68 04/15/2024 Food and Beverage Undisputed 01/23/2026 1086846131 CMS
Novartis Pharmaceuticals Corporation $7.13 04/29/2024 Food and Beverage Undisputed 01/23/2026 1086846133 CMS
Novartis Pharmaceuticals Corporation $5.34 05/17/2024 Food and Beverage Undisputed 01/23/2026 1086846139 CMS
Novartis Pharmaceuticals Corporation $14.87 05/17/2024 Food and Beverage Undisputed 01/23/2026 1086846141 CMS
Novartis Pharmaceuticals Corporation $6.09 05/24/2024 Food and Beverage Undisputed 01/23/2026 1086846135 CMS
Novartis Pharmaceuticals Corporation $8.86 06/07/2024 Food and Beverage Undisputed 01/23/2026 1086846137 CMS
Novartis Pharmaceuticals Corporation $13.82 07/26/2024 Food and Beverage Undisputed 01/23/2026 1086846145 CMS
Novartis Pharmaceuticals Corporation $19.22 08/14/2024 Food and Beverage Undisputed 01/23/2026 1086846147 CMS
Novartis Pharmaceuticals Corporation $26.98 08/20/2024 Food and Beverage Undisputed 01/23/2026 1086846151 CMS
Novartis Pharmaceuticals Corporation $31.18 08/28/2024 Food and Beverage Undisputed 01/23/2026 1086846153 CMS
Novartis Pharmaceuticals Corporation $4.80 09/06/2024 Food and Beverage Undisputed 01/23/2026 1086846155 CMS
Novartis Pharmaceuticals Corporation $7.80 09/17/2024 Food and Beverage Undisputed 01/23/2026 1086846159 CMS
Novartis Pharmaceuticals Corporation $2.13 09/17/2024 Food and Beverage Undisputed 01/23/2026 1086846161 CMS
Novartis Pharmaceuticals Corporation $34.05 10/16/2024 Food and Beverage Undisputed 01/23/2026 1086846165 CMS
Novartis Pharmaceuticals Corporation $10.07 11/13/2024 Food and Beverage Undisputed 01/23/2026 1086846167 CMS
PFIZER INC. $38.65 07/14/2024 Food and Beverage Undisputed 01/23/2026 1131747352 CMS
SANOFI-AVENTIS U.S. LLC $33.21 03/27/2024 Food and Beverage Undisputed 01/23/2026 1139592034 CMS
SCPHARMACEUTICALS INC. $21.77 04/10/2024 Food and Beverage Undisputed 01/23/2026 1132267087 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.